DEF 14A Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 21, 2006

Period of Report

June 9, 2006

Accession Number

0001206774-06-000842

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →